데이터셋 상세
미국
COVID-19 Test to Treat
NOTE: This dataset is no longer updated as of 1/31/2024. Please use COVID-19 Treatments. Data Information and Disclaimers The locations displayed above have received an order of Paxlovid or Lagevrio (molnupiravir) in the last two months and/or have reported availability of the oral antiviral medications within the last two weeks. Those sites that have not reported in the last two weeks display a notification with the site details, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." All therapeutics identified in the locator must be used in alignment with the terms of the respective product’s EUA. Data displayed on this page is for informational purposes only. The data on this page is for locations with the oral antivirals Pfizer's Paxlovid and Merck's Lagevrio (molnupiravir). Visit COVID-19 Treatments and Therapeutics for more information on all treatment options. The medication is provided at no cost. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites. Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).
데이터 정보
연관 데이터
COVID-19 Cases by Vaccination Status - ARCHIVE
공공데이터포털
Note: As of 10/28/2021 this dataset is no longer being updated. For more information about COVID-19 cases by vaccination status, visit the Department of Public Health's daily report here: https://data.ct.gov/stories/s/q5as-kyim Cases of COVID-19 by vaccination status by weekly reporting period. All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected. Since February 2021, cases of COVID-19 among fully vaccinated persons (e.g., vaccine breakthrough cases) were identified based on a medical provider report to DPH identifying such cases. Recently, DPH developed a process that matches COVID-19 case data with the vaccine registry to determine which cases meet the definition of being fully vaccinated and are also vaccine breakthrough cases. A case of COVID-19 in a fully vaccinated person (e.g., vaccine breakthrough case) is defined as a person who has a positive PCR/NAAT or antigen test in a respiratory specimen collected ≥14 days after completing the final dose of an FDA-authorized or approved COVID-19 vaccine series and who did not have a previously positive COVID-19 test <45 days prior to the positive test currently under investigation. This newer process provides more accurate and complete data on the vaccine status of persons who have tested positive for COVID-19.
COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series
공공데이터포털
,After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.,